Association between harm reduction strategies and healthcare utilization in patients on long-term prescribed opioid therapy presenting to acute healthcare settings: a protocol for a systematic review and meta-analysis.
Addiction medicine
Drug abuse
Hospital medicine
Narcotics
Substance-related disorders
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
05 04 2019
05 04 2019
Historique:
received:
02
03
2018
accepted:
25
03
2019
entrez:
7
4
2019
pubmed:
7
4
2019
medline:
10
5
2020
Statut:
epublish
Résumé
Opioids are routinely used to treat a variety of chronic conditions associated with pain. However, they are a class of medications with a significant potential for adverse health effects, with and without misuse. Opioid misuse, as defined as inappropriate use of appropriately prescribed opioids, is becoming more well-recognized publicly but does not have clear treatment options. Opioid misuse has been linked to variety of poor outcomes and its consequences have a significant impact on healthcare resource utilization. The evidence on harm reduction strategies to mitigate adverse events prompting presentation to acute care settings for patients presenting with long-term opioid use is sparse. We will perform a systematic review and meta-analysis to catalog effective harm reduction strategies and identify the most effective ones to reduce avoidable healthcare utilization in patients on long-term opioid therapy who present to acute health care settings with complications attributed to opioid misuse. A search strategy will be developed and executed by an information specialist; electronic databases (MEDLINE, EMBASE, CINAHL, Cochrane Library) and additional sources will be searched. Search themes will include opioids, chronic drug use, and acute healthcare settings. Citation screening, selection, quality assessment, and data abstraction will be performed in duplicate. A comprehensive inventory of harm reduction strategies will be developed. Data will be collected on patient-related outcomes associated with each identified harm reduction strategy. When sufficiently homogeneous data on interventions, population, and outcomes is available, it will be pooled for aggregate analysis. Evaluation of the methodological quality of individual studies and of the quality of the body of evidence will be performed. Our primary objective will be to identify harm reduction strategies that have been shown to result in clinically relevant and statistically significant improvements in patient outcomes and/or decreased healthcare utilization. This study will better characterize harm reduction strategies for patients on long-term prescribed opioids presenting to acute healthcare settings. It will also add new knowledge and generate greater understanding of key knowledge gaps of the long-term prescribed opioid use and its impact on healthcare utilization. CRD42018088962 .
Identifiants
pubmed: 30953550
doi: 10.1186/s13643-019-0997-5
pii: 10.1186/s13643-019-0997-5
pmc: PMC6449896
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
88Références
Pain Res Manag. 2003 Winter;8(4):189-94
pubmed: 14679412
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
J Crit Care. 2017 Feb;37:261
pubmed: 27876483
Addiction. 2008 Sep;103(9):1500-8
pubmed: 18636996
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
J Intensive Care Med. 2017 Aug;32(7):429-435
pubmed: 26609023
J Hosp Med. 2014 Feb;9(2):73-81
pubmed: 24227700
Inj Prev. 2018 Feb;24(1):48-54
pubmed: 28835443
Popul Health Manag. 2014 Dec;17(6):372-87
pubmed: 25075734
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
BMJ. 2018 Aug 1;362:k2833
pubmed: 30068513
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
BMJ. 2016 Jun 28;353:i2016
pubmed: 27353417
Can Fam Physician. 2014 Sep;60(9):826-32
pubmed: 25217680
J Trauma. 2007 Mar;62(3):755-8
pubmed: 17414360
JAMA. 2016 Apr 19;315(15):1624-45
pubmed: 26977696
J Opioid Manag. 2012 Mar-Apr;8(2):81-7
pubmed: 22616313
J Pain Symptom Manage. 1996 Apr;11(4):203-17
pubmed: 8869456
South Med J. 2017 Mar;110(3):217-222
pubmed: 28257549
Ann Intensive Care. 2017 Sep 2;7(1):88
pubmed: 28866754
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452
pubmed: 28033313
BMJ. 2008 May 17;336(7653):1106-10
pubmed: 18483053
Ann Intern Med. 2010 Jan 19;152(2):85-92
pubmed: 20083827
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
J Pain Symptom Manage. 1996 May;11(5):274-86
pubmed: 8636626
Can J Pain. 2017 May 4;1(1):2-7
pubmed: 35005336
J Pain Symptom Manage. 1993 Jul;8(5):265-78
pubmed: 7525743
Clin J Pain. 2002 Jul-Aug;18(4 Suppl):S28-38
pubmed: 12479252
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Eur J Pain. 2007 Jul;11(5):490-518
pubmed: 17070082
Arch Intern Med. 2003 Sep 22;163(17):2014-8
pubmed: 14504113
Ann Am Thorac Soc. 2017 Dec;14(12):1803-1809
pubmed: 28800256
Int J Technol Assess Health Care. 2012 Apr;28(2):138-44
pubmed: 22559755
JAMA. 1999 Jul 21;282(3):267-70
pubmed: 10422996
J Stud Alcohol Drugs. 2011 Sep;72(5):774-86
pubmed: 21906505
J Trauma Acute Care Surg. 2014 Jan;76(1):172-5
pubmed: 24368374
Pain Ther. 2017 Dec;6(2):203-215
pubmed: 28887789